Service alert

Current CAP Guidelines

The Center evidence-based guidelines help pathologists and other clinicians make more informed decisions about diagnosis and optimal treatment, and place emphasis on the pathologist’s role to the center of patient care. Learn more about our guideline development.

  1. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma – 2026 Update
  2. Interpretive Diagnostic Error Reduction – 2026 Update
  3. Laboratory Workup of Amyloidosis
  4. Human Papillomavirus Testing in Head and Neck Carcinomas – 2025 Update
  5. PDL-1 and TMB Testing in Lung Tumors
  6. Principles of Analytic Validation of Immunohistochemical Assays – 2024 Update
  7. HER2 Testing in Breast Cancer – 2023 Update
  8. Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy
  9. Diagnostic Testing for Diffuse Gliomas
  10. Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies
  11. Validating Whole Slide Imaging for Diagnostic Purposes in Pathology – 2021 Update
  12. Laboratory Workup of Lymphoma in Adults
  13. Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies
  14. Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer – 2020 Update
  15. Quantitative Image Analysis of HER2 IHC for Breast Cancer – Inactive
  16. Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors – 2018 Update
  17. Effective Communication of Urgent Diagnoses and Significant Unexpected Diagnoses in Surgical Pathology and Cytopathology – Inactive
  18. Initial Diagnostic Workup of Acute Leukemia
  19. Molecular Biomarkers for the Evaluation of Colorectal Carcinoma
  20. Bone Marrow Synoptic Reporting for Hematologic Neoplasms – Inactive
  21. Uniform Labeling of Blocks and Slides in Surgical Pathology – Inactive
  22. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions

External Guidelines Endorsed by the CAP

The following guidelines produced by other organizations have been evaluated by the Center Guideline Committee and officially endorsed by the CAP.

American Society of Clinical Oncology Molecular and Cellular Diagnostics in Localized Prostate Cancer
Date endorsed: August 14, 2020

  • Read the editorial discussing the role of the pathologist in the molecular and cellular diagnosis of prostate cancer.